BACKGROUND: Despite an increased propensity to primary failure in forearm arteriovenous fistulae compared with upper arm fistulae, forearm fistulae remain the preferred primary access type for chronic hemodialysis patients. In a high risk patient population with multiple medical comorbidities associated with requirement for intravenous access we compared the rates of access failure in forearm and upper arm fistulae. MATERIALS AND METHODS: The records of all patients having primary native arteriovenous fistulae placed between 2004 and 2009 at the VA Connecticut Healthcare system were reviewed (n = 118). Primary and secondary patency of upper arm and forearm fistulae were evaluated using Kaplan-Meier survival analysis. The effects of medical comorbidities on access patency were analyzed with Cox regression. RESULTS: The median time to primary failure of the vascular access was 0.288 y in the forearm group compared with 0.940 y in the upper arm group (P = 0.028). Secondary patency was 52% at 4.9 y in upper arm fistulae compared with 52% at 1.1 y in the forearm group (P = 0.036). There was no significant effect of patient comorbidities on fistula failure; however, there was a trend toward upper arm surgical site as a protective factor for primary fistula patency (hazard ratio = 0.573, P = 0.076). CONCLUSIONS: In veterans needing hemodialysis, a high risk population with extensive comorbid factors often requiring intravascular access, upper arm fistulae are not only a viable option for primary vascular access, but are likely to be a superior option to classic forearm fistulae. Published by Elsevier Inc.
BACKGROUND: Despite an increased propensity to primary failure in forearm arteriovenous fistulae compared with upper arm fistulae, forearm fistulae remain the preferred primary access type for chronic hemodialysis patients. In a high risk patient population with multiple medical comorbidities associated with requirement for intravenous access we compared the rates of access failure in forearm and upper arm fistulae. MATERIALS AND METHODS: The records of all patients having primary native arteriovenous fistulae placed between 2004 and 2009 at the VA Connecticut Healthcare system were reviewed (n = 118). Primary and secondary patency of upper arm and forearm fistulae were evaluated using Kaplan-Meier survival analysis. The effects of medical comorbidities on access patency were analyzed with Cox regression. RESULTS: The median time to primary failure of the vascular access was 0.288 y in the forearm group compared with 0.940 y in the upper arm group (P = 0.028). Secondary patency was 52% at 4.9 y in upper arm fistulae compared with 52% at 1.1 y in the forearm group (P = 0.036). There was no significant effect of patient comorbidities on fistula failure; however, there was a trend toward upper arm surgical site as a protective factor for primary fistula patency (hazard ratio = 0.573, P = 0.076). CONCLUSIONS: In veterans needing hemodialysis, a high risk population with extensive comorbid factors often requiring intravascular access, upper arm fistulae are not only a viable option for primary vascular access, but are likely to be a superior option to classic forearm fistulae. Published by Elsevier Inc.
Authors: Allan J Collins; Bertram Kasiske; Charles Herzog; Blanche Chavers; Robert Foley; David Gilbertson; Richard Grimm; Jiannong Liu; Thomas Louis; Willard Manning; Arthur Matas; Marshall McBean; Anne Murray; Wendy St Peter; Jay Xue; Qiao Fan; Haifeng Guo; Shuling Li; Suying Li; Tricia Roberts; Jon Snyder; Craig Solid; Changchun Wang; Eric Weinhandl; Cheryl Arko; Shu-Cheng Chen; Frederick Dalleska; Frank Daniels; Stephan Dunning; James Ebben; Eric Frazier; Roger Johnson; Daniel Sheets; Beth Forrest; Delaney Berrini; Edward Constantini; Susan Everson; Pamela Frederick; Paul Eggers; Lawrence Agodoa Journal: Am J Kidney Dis Date: 2005-01 Impact factor: 8.860
Authors: Kota Yamamoto; Clinton D Protack; Masayuki Tsuneki; Michael R Hall; Daniel J Wong; Daniel Y Lu; Roland Assi; Willis T Williams; Nirvana Sadaghianloo; Hualong Bai; Tetsuro Miyata; Joseph A Madri; Alan Dardik Journal: Am J Physiol Heart Circ Physiol Date: 2013-10-04 Impact factor: 4.733
Authors: Susan K Morton; Alexander J Rodríguez; Dylan R Morris; Abhishta P Bhandari; Joseph V Moxon; Jonathan Golledge Journal: PLoS One Date: 2016-07-26 Impact factor: 3.240